Acelity Adds to Board

San Antonio, Texas-based Acelity L.P. Inc., a wound care and regenerative medicine company, has added Kevin J. Buehler and Alexandre Décary to its board of directors. Buehler and Décary bring tremendous business acumen and unique expertise that will strengthen Acelity’s presence on a global scale.

“Kevin and Alexandre bring strong experiences in both global business and finance that will add unique and valuable perspectives to Acelity’s Board,” said Joe Woody, president and CEO of Acelity. “Kevin brings extensive management experience in the healthcare industry and Alexandre has a tremendous financial and corporate leadership background; collectively, their counsel will help to guide Acelity’s growth as a global leader in wound care and regenerative medicine.”

Buehler has more than 30 years of experience in the healthcare and consumer industries, with knowledge of U.S. and international operations. He has a distinguished career, most recently serving as the division head of Alcon Laboratories Inc., a division of Novartis, from April 2011 to May 2014. Buehler has held a variety of leadership positions within the Alcon Laboratories organization, including: Senior vice president of global markets, chief marketing officer, and president and CEO of Alcon Inc. He served on the board of directors for Alcon prior to the merger with Novartis. He holds a B.A, from Carroll College in Waukesha, Wis., with concentrations in business administration and political science. He is a graduate of the Harvard Program for Management Development.

Décary brings strong business, financial and accounting experience to Acelity. Currently, Décary serves as senior director, private equity, at PSP Investments, where he is responsible for leading direct investments in various sectors. Prior to joining PSP Investments in 2015, he was vice president, mergers and acquisitions, at Aimia Inc., a data-driven marketing and loyalty analytics company where he was responsible for the company’s growth through strategic investments and acquisitions in the G20. From 2004 to 2012, he worked at RBC Capital Markets in the investment banking group where he had coverage responsibility for Canadian companies across various sectors. He began his career at Ernst & Young LLP in the audit and corporate finance departments. Décary completed a bachelor’s degree in business administration and a graduate diploma in public accountancy degree from HEC Montréal, as well as a masters in finance degree from the London Business School. He holds the CPA (Certified Public Accountant) designation in Canada and CFA (Chartered Financial Analyst) designation.